This is a StreetInsider.com Premium Only Page

Meridian Bioscience (VIVO) – StreetInsider.com Reports

Jan 26, 2023 05:49 AM Meridian Bioscience (VIVO) to Join S&P SmallCap 600

Jan 25, 2023 05:43 PM DoubleVerify (DV) to be added to S&P SmallCap 600

Dec 12, 2022 08:17 AM Meridian Bioscience (VIVO) has entered into a side letter with the buyer, setting the closing date of Meridian's pending merger for January 31

Aug 5, 2022 08:03 AM Meridian Bioscience (VIVO) Misses Q3 EPS by 1c

Jul 29, 2022 09:23 AM Meridian Bioscience (VIVO) Granted FDA Re-Authorization for Revogene SARS-CoV-2 Molecular Assay

Jul 8, 2022 06:27 AM UPDATE: H.C. Wainwright Downgrades Meridian Biosciences (VIVO) to Neutral

Jul 7, 2022 11:12 AM Meridian Biosciences (VIVO) PT Maintained at William Blair

Jul 7, 2022 07:26 AM Meridian Bioscience (VIVO) to Resume Trading at 7:45 a.m.

Jul 7, 2022 07:18 AM Meridian Bioscience (VIVO) to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction, $34 Per Share

Jul 7, 2022 07:14 AM Meridian Bioscience (VIVO) Prelim. Q3 Revenue Misses Consensus

Jul 7, 2022 07:03 AM Meridian Bioscience (VIVO) Halted, News Pending

May 26, 2022 01:33 PM Meridian Bioscience (VIVO) to Help Develop Monkeypox Tests

May 17, 2022 03:33 PM Meridian Bioscience (VIVO) Launches Lyo-Ready Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic Assays

May 6, 2022 08:07 AM Meridian Bioscience (VIVO) Tops Q2 EPS by 35c

May 2, 2022 08:48 AM Meridian Bioscience (VIVO) Acquires EUPROTEIN

Apr 7, 2022 08:36 AM Meridian Bioscience (VIVO) Guides Q2 Revenue to be in $109M-$113M Range

Mar 29, 2022 02:37 PM Meridian Bioscience (VIVO) Launches Lyo-Ready qPCR Inhibitor Tolerant Blood-Specific Master Mixes for DNA & RNA Direct Detection

Feb 22, 2022 05:37 AM Meridian Bioscience (VIVO) Appoints Andy Kitzmiller as CFO

Feb 7, 2022 06:19 AM Meridian Biosciences (VIVO) PT Raised to $30 at H.C. Wainwright

Feb 4, 2022 08:03 AM Meridian Bioscience (VIVO) Tops Q1 EPS by 10c; Offers 2022 Guidance

Jan 31, 2022 11:45 AM Meridian Bioscience (VIVO) Receives Additional NIH Award to Support the Rapid Development of the Revogene® Molecular Viral Respiratory Testing Panel

Jan 28, 2022 10:05 AM Meridian Bioscience (VIVO) Launches Lyo-Ready qPCR Saliva-Specific Master Mixes for DNA & RNA Direct Detection

Jan 27, 2022 02:05 PM Meridian Bioscience (VIVO) Elects John C. McIlwraith New Chairman of the Board

Jan 5, 2022 10:15 AM Meridian Bioscience (VIVO) Receives FDA-Clearance for the Curian Campy Assay

Dec 9, 2021 12:53 PM Meridian Bioscience (VIVO) Revogene test expected to fail to detect Omicron, won't distribute in U.S. until issue is resolved - Bloomberg

Dec 2, 2021 08:07 AM Meridian Bioscience (VIVO) Announces Retirement of CFO Bryan Baldasare

Nov 24, 2021 09:05 AM Meridian Bioscience (VIVO) Announces Retirement of Chairman David Phillips

Nov 15, 2021 06:43 AM Meridian Biosciences (VIVO) PT Raised to $28 at H.C. Wainwright

Nov 12, 2021 07:32 AM Meridian Bioscience (VIVO) Tops Q4 EPS by 3c

Nov 10, 2021 08:55 AM Meridian Bioscience (VIVO) Receives FDA Emergency Use Authorization for Revogene SARS-CoV-2 Molecular Assay

Oct 7, 2021 02:02 PM Meridian Bioscience (VIVO) Launches New Air-Dryable qPCR Mix Enabling Direct Detection of RNA from Whole Blood Samples

Sep 7, 2021 10:03 AM Meridian Bioscience (VIVO) Launches Two Air-Dryable Mixes qPCR for Direct Detection of DNA or RNA from Saliva Samples

Aug 9, 2021 07:08 AM Meridian Biosciences (VIVO) PT Lowered to $27 at H.C. Wainwright

Jul 23, 2021 09:21 AM Meridian Bioscience (VIVO) to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.

Jul 13, 2021 09:06 AM Meridian Bioscience (VIVO) Announces Preliminary Revenue Results for Q3

Jun 28, 2021 09:25 AM Meridian Bioscience (VIVO) Resubmits Application to FDA for Emergency Use Authorization for Revogene SARS-CoV-2 Molecular Assay

May 10, 2021 06:51 AM Meridian Biosciences (VIVO) PT Lowered to $30 at H.C. Wainwright

May 7, 2021 07:40 AM Meridian Bioscience (VIVO) Tops Q2 EPS by 8c, Offers Guidance

Apr 1, 2021 09:00 AM Meridian Bioscience (VIVO) Announces FDA Submission for New Curian Campy Assay

Feb 23, 2021 08:06 AM Meridian Bioscience (VIVO) Provides Further Update on Revogene SARS-CoV-2 EUA Submission

Feb 16, 2021 08:12 AM Meridian Bioscience (VIVO) Provides Update on Revogene SARS-CoV-2 EUA Submission

Feb 8, 2021 07:11 AM Meridian Biosciences (VIVO) PT Raised to $34 at Piper Sandler

Jan 7, 2021 08:03 AM Meridian Bioscience (VIVO) Prelim. Q1 Revenue Tops Consensus

Dec 8, 2020 10:17 AM Meridian Bioscience (VIVO) submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay

Nov 16, 2020 08:46 AM Meridian Biosciences (VIVO) PT Raised to $26 at Piper Sandler

Nov 13, 2020 07:34 AM Meridian Bioscience (VIVO) Reports Q4 EPS of $0.19, Offers FY21 Guidance

Sep 14, 2020 10:01 AM Meridian Bioscience (VIVO) launches novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva samples

Aug 11, 2020 04:34 AM Piper Sandler Reinstates Meridian Biosciences (VIVO) at Overweight

Jul 28, 2020 09:03 AM Meridian Bioscience (VIVO) Adds Anthony Bihl III to Board

Jul 27, 2020 06:35 AM UPDATE: H.C. Wainwright Starts Meridian Biosciences (VIVO) at Buy